799PD - Phase I dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)
| Autor: | Tagawa, S.T., Vallabhajosula, S., Jhanwar, Y., Hackett, A., Oromendia, C., Naiz, M.J., Goldsmith, S.J., Nanus, D.M., Beltran, H., Molina, A.M., Faltas, B., Sreekumar, J., Babich, J., Ballman, K., Bander, N.H. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|